The epithelial splicing regulator ESRP2 is epigenetically repressed by DNA hypermethylation in Wilms tumour and acts as a tumour suppressor. (2022)

First Author: Legge D
Attributed to:  Anti-angiogenic compounds based on modulation of VEGF splicing funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/1878-0261.13101

PubMed Identifier: 34520622

Publication URI: http://europepmc.org/abstract/MED/34520622

Type: Journal Article/Review

Volume: 16

Parent Publication: Molecular oncology

Issue: 3

ISSN: 1574-7891